Replies to post #2521 on Filana Therapeutics Inc (FLNA)

[runncoach]

No. Unless someone has any info to the contrary which I have not seen, nor would make sense IMO.

Cassava is where they need to be. They are running their first placebo controlled trial. They are making sure 100 mg is the proper dose and they are making it big enough for the FDA to grant approval if efficacy is shown. As with all drug stocks, you get to a point where you have to have patience before you see results. Stock could go down. Stock could go up but regardless its a 2 year wait now. Even IF, and I give this almost no chance, they have an interim readout you are still talking 18 months. Company has given no indication of such either and what some don't understand is it hurts your probability model by peaking. Patience.

[McMagyar]

Always a chance
Dementia is a death sentence
The results are off the charts
The safety is off the charts

There is NO reason death sentences patien ta are bot allowed access other than
FDA, BP, and owners of memory care facilities and directors of
Dementia associations (who take big bucks from all of the above) being hell bent against it..

But they are more powerful than elderly death sentences relations ..